LCN2 and metabolic disease: Changes in the production of adipokines such as leptin, resistin, lipocalin 2, tumor necrosis factor-α, chemerin, retinol binding protein 4, and interleukin-6 have been reported in obese individuals, and this can lead to the development of obesity-related metabolic diseases.